Top Buy
Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Eli Lilly Corp. | 50 | 0 | 5 | 0 | €698.90 | €766.92 | 9.732% |
Boston Scientific | 46 | 0 | 10 | 0 | €68.00 | €73.05 | 7.422% |
Biogen Inc. | 46 | 1 | 6 | 1 | €205.10 | €294.01 | 43.350% |
Vertex Pharmaceuticals Inc. | 45 | 2 | 7 | 0 | €393.30 | €406.87 | 3.450% |
Alnylam Pharmace. | 36 | 0 | 3 | 0 | €142.70 | €236.30 | 65.591% |
Regeneron Pharmaceuticals Inc. | 34 | 1 | 5 | 0 | €907.00 | €957.22 | 5.537% |
Intuitive Surgical Inc | 34 | 0 | 2 | 0 | €357.05 | €376.15 | 5.350% |
UnitedHealth Group Inc. | 33 | 1 | 2 | 0 | €475.50 | €543.72 | 14.347% |
Johnson & Johnson | 32 | 1 | 3 | 0 | €138.94 | €196.74 | 41.598% |
Pfizer Inc. | 31 | 4 | 3 | 0 | €26.15 | €41.10 | 57.182% |
Tenet Healthcare | 28 | 0 | 5 | 0 | €117.00 | €121.69 | 4.011% |
Merck & Co. Inc. | 28 | 1 | 1 | 0 | €119.40 | €124.93 | 4.631% |
Neurocrine Bioscience | 28 | 0 | 7 | 0 | €127.60 | €140.34 | 9.984% |
Thermo Fisher Scientific Inc. | 26 | 0 | 4 | 0 | €547.50 | €568.09 | 3.761% |
Edwards Lifesciences Corp. | 26 | 1 | 3 | 0 | €80.67 | €88.14 | 9.257% |
Cytokinetics Inc. | 26 | 1 | 3 | 0 | €58.00 | €84.57 | 45.813% |
Amgen Inc. | 25 | 0 | 5 | 0 | €286.05 | €297.31 | 3.937% |
Intra-Cellular Therapies Inc. | 24 | 0 | 7 | 0 | €59.50 | €79.55 | 33.705% |
Stryker Corp. | 23 | 0 | 7 | 0 | €304.90 | €335.03 | 9.882% |
Humana Inc. | 23 | 0 | 3 | 0 | €314.80 | €439.88 | 39.732% |
Zoetis Inc. A | 23 | 1 | 5 | 0 | €157.00 | €200.06 | 27.425% |
HCA Holdings Inc. | 22 | 0 | 4 | 0 | €305.10 | €303.80 | -0.427% |
TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €15.42 | €28.06 | 81.953% |
AbbVie Inc. | 21 | 0 | 4 | 0 | €150.00 | €174.43 | 16.289% |
Iovance Biotherapeutics Inc. | 20 | 4 | 1 | 1 | €10.31 | €22.78 | 120.905% |